Cite
HARVARD Citation
Jensen, S. et al. (n.d.). 480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12. Journal for immunotherapy of cancer. p. A296. [Online].